You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLA

Showing 1 - 25 of 3,101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obstetrical History and Anti-HLA Antibodies Level

Not yet recruiting
  • Blood Donors
  • Anti-HLA Antibody
  • Obstetrical history
  • Anti-HLA Antibody tests
  • Bordeaux, France
    Etablissement Français du Sang Nouvelle Aquitaine
Aug 25, 2023

Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

Not yet recruiting
  • Head and Neck Cancer
  • +8 more
  • Tumor and HLA Profiling
  • (no location specified)
Mar 31, 2023

Neonatal Sepsis Trial in Sohag (CD64 , HLA-DR)

Not yet recruiting
  • Neonatal Sepsis
  • CD64 , HLA-DR
  • Sohag, Egypt
    Sohag University hospitals
Aug 7, 2023

Solid Tumor Trial in Houston (Single Injection of IVS-3001- Anti - HLA-G CAR-T cells, Fludarabine phosphate, Cyclophosphamide)

Not yet recruiting
  • Solid Tumor
  • Single Injection of IVS-3001- Anti - HLA-G CAR-T cells
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Lung Graft Dysfunction Trial (Blood collection T0, Blood collection 6 months)

Not yet recruiting
  • Lung Graft Dysfunction
  • Blood collection T0
  • Blood collection 6 months
  • (no location specified)
Oct 27, 2023

Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

Recruiting
  • Hematologic Malignancies
  • Haplo HCT <55 years old
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 25, 2023

Maternal KIR and Fetal HLA Influence Reproductive Success in

Recruiting
  • Reproductive Issues
  • Analysis combinations of maternal KIR and HLA-C genotypes
  • Madrid, Spain
    Instituto Valenciano de Infertilidad
Nov 30, 2022

Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

Not yet recruiting
  • Severe Aplastic Anemia
  • (no location specified)
Oct 1, 2023

HLA Genes and Innate Immunity in Phenotypic Variability of

Completed
  • COVID-19
  • HLA-genotyping
  • Roma, Rm, Italy
    Francesco Danilo Tiziano
Feb 6, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Beijing protocol
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Jun 19, 2023

Expanding Scope of Post-transplant HLA-specific Antibody

Not yet recruiting
  • Kidney Transplant
  • +7 more
  • cf-DNA
  • +2 more
  • Liverpool, Merseyside, United Kingdom
    Liverpool University Hospitals NHS Foundation Trust
Aug 29, 2023

HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cancer
  • cell culture
  • Roma, Lazio, Italy
    Fondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023

HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

Recruiting
  • Drug Monitoring
  • Inflammatory Bowel Diseases
  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Valladolid, Spain
    Hospital Universitario Rio Hortega
Aug 8, 2023

Eye Diseases, Uveitis Trial in Leuven (Abatacept 125 MG/ML Prefilled Syringe)

Active, not recruiting
  • Eye Diseases
  • Uveitis
  • Abatacept 125 MG/ML Prefilled Syringe
  • Leuven, Vlaams-Brabant, Belgium
    UZLeuven
Jan 26, 2023

MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

Recruiting
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia
  • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
  • Standard of Care Chemotherapy
  • Tampa, Florida
    Moffitt Cancer Center
Sep 27, 2022

Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)

Not yet recruiting
  • Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
  • (no location specified)
Mar 3, 2023

Tissue Specimens From Solid Tumors or Blood Disorders and Their

Recruiting
  • Neoplasms
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Non-gal, Non-HLA Antigens in Patients Implanted With Xenogenic

    Recruiting
    • Valve Heart Disease
    • blood draw
    • Phoenix, Arizona
    • +2 more
    Dec 6, 2022

    Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages

    Completed
    • Recurrent Miscarriages
      • London, United Kingdom
        St. Mary's Hospital
      Aug 4, 2022

      GVHD Trial (Grafalon, Thymoglobulin)

      Not yet recruiting
      • GVHD
      • (no location specified)
      Oct 9, 2023

      Covid19 Trial in Suresnes (Baseline and during hospitalization blood samples, Baseline blood sample)

      Completed
      • Covid19
      • Baseline and during hospitalization blood samples
      • Baseline blood sample
      • Suresnes, France
        Foch hospital
      Aug 2, 2022

      Monocyte Expression of Human Leukocyte Antigen - DR Isotype

      Recruiting
      • Critical Care
      • Blood sampling
      • Lyon, France
        Service de reanimation chirurgicale
      Oct 27, 2022

      Rejection; Transplant, Liver, Liver Failure, Liver Diseases Trial in Cambridge, London (QEL-001)

      Recruiting
      • Rejection; Transplant, Liver
      • +2 more
      • Birmingham, United Kingdom
      • +3 more
      Dec 22, 2022

      Ependymoma Trial in Pittsburgh (biological, drug, other)

      Recruiting
      • Ependymoma
      • HLA-A2 restricted synthetic tumor antigen
      • +5 more
      • Pittsburgh, Pennsylvania
        Children's Hospital of Pittsburgh of UPMC
      Oct 23, 2022